The weekly litigation news digest is live. Subscribe now

IP Verse

Improved Protocol For Treatment Of Lupus Nephritis - EP3634463

The patent EP3634463 was granted to Aurinia Pharmaceuticals on Jan 10, 2024. The application was filed on May 11, 2018 under application number EP18798594A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3634463

AURINIA PHARMACEUTICALS
Application Number
EP18798594A
Filing Date
May 11, 2018
Status
Granted And Under Opposition
Aug 25, 2023
Publication Date
Jan 10, 2024
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (5)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
GALENICUM HEALTH SLUJun 27, 2024GALENICUM HEALTH SLUADMISSIBLE
BOTTI & FERRARIJun 26, 2024BOTTI & FERRARIADMISSIBLE
HAMM & WITTKOPPJun 26, 2024HAMM & WITTKOPPADMISSIBLE
MAIWALDJun 26, 2024MAIWALDADMISSIBLE
TEVA PHARMACEUTICALSJun 26, 2024KRAUS & LEDERER PARTGMBBADMISSIBLE

Patent Citations (8) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS6998385
DESCRIPTIONUS7060672
DESCRIPTIONUS7332472
DESCRIPTIONUS7429562
DESCRIPTIONUS7829533
OPPOSITIONUS10286036
OPPOSITIONUS201762541612P
OPPOSITIONUS7332472

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents